3Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
4Shlomai A, Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003, 37:764-770.
5Mancini M, Davis H, Tiollais P, Michel ML. DNA-based immunization against the envelope proteins of the hepatitis B virus. J Biotechnol 1996,44:47-57.
6Wang Y, Cui F, Lti Y, Li C, Xu X, Deng C, Wang D et al. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice.Hepatology 2004, 39:318-24.
7Nakamoto Y, Suda T, Momoi T, Kaneko S. Different procarcinogenic potentials of lymphocyte subsets in a transgenic mouse model of chronic hepatitis B. Cancer Res 2004, 64:3326-3333.
8Gagrica S, Hauser S, Kolfschoten I, Osterloh L, Agami R, Gaubatz S.Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein. EMBO J 2004, 23:4627-4638.
9Cheng JC, Sakamoto KM. The emerging role of RNA interference in the design of novel therapeutics in oncology. Cell Cycle 2004, 3:1398-401.
10Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV et al. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 2004, 6:8184-8192.
